HIMSS & Health 2.0 Japan 2019

Pitch Competition

Entry Closed

The Gateway to Success for Healthcare Startups! Discover the Next Generation Startups/Service to Support the Era to Live 100 Years.

This is a well known pitch event within Health 2.0 Asia - Japan where many startups will pitch their latest technology/solution seeking for new collaboration.
Finalists shall pitch and discuss their business with judges, and what’s more for this year, more than 50 startups shall be on stage for the pitch through 2 days!!

The growing market of Healthtech, HIMSS & Health 2.0 Japan will support startups who provide solutions for how human live better through the cradle to the grave with technology.

Our Features

No.1 Healthtech in 2019 Startup Will Be Presented

No.1 Healthtech in 2019 Startup Will Be Presented

6 Finalists are pitching in main stage, showing idea and technology to update Healthcare.

Don’t Miss the Q&As Between the Startup and the Judges!

Don’t Miss the Q&As Between the Startup and the Judges!

As well as 5minutes pitch, we consider 10minutes Q&As with our knowledge-full judges to decide which to win. Various perspectives must inspire your business sense.

More than 50 Startups Shall Pitch Through 2 Days.

More than 50 Startups Shall Pitch Through 2 Days.

More than 50 startups can pitch in Lightning Pitch in first day. With the live streaming, 1 startup shall advance to the Pitch Final.

Lightning Pitch

December 9th, "Lightning Pitch"
Be a part of the event by live streaming and voting!

Lightning Pitch where the audience shall choose the final 1 Finalist for the Pitch Final on December 10th. Don't miss the live streaming and join the live voting.

facebook Official facebook


Time Group Place
10:20~11:40 GroupA HallB
Muromachi Mitsui Hall & Conference
12:10~13:30 GroupB
14:00~15:20 GroupC
Vote by 4:00p.m. or you'll miss it !
17:15~17:25 Lightning Pitch Award HallA
Nihonbashi Mitsui Hall

※The schedule may change depending on the progress.

Lightning Pitch Panelist

  • Holo-Light
  • Playbrush
  • SCARLETRED Holding
  • Scio TEchnologies
  • Medicus AI
  • Triple Regards LLC
  • travoss
  • Mitsui Medical Clinic
  • oseirt association
  • .Tech Inc.
  • ViewSend ICT
  • Universal Sound Design
  • Japan mode
  • Z-Works
  • silvereye
  • melody.international
  • bspr
  • Risk Measurement Technologies
  • a10lab
  • Varinos
  • nagomi
  • mentalcompass
  • iCorNet
  • ANOKORO communications
  • wa-conpro
  • healthbit
  • Bipolar Diary
  • Kenkou Data House
  • Yukai Engineering
  • karada-portal
  • zest
  • quinsence
  • nokatsusoken
  • bitBiome
  • open-socio
  • kyo-diagnostics
  • Connect
  • ad-dice
  • remarkgroup
  • caitech
  • Buzzreach
  • fullstem
  • F Treatment


Recruiting Period
Entry Closed
Sep.17th - Oct.31st 2019

1,000,000JPY / 2 invitation tickets to Health 2.0 Annual Conference 2020 in USA

* For the winner
* Sponsor Award is selected separately.

  • Product/service need to be in the healthtech region*1
  • Product/service have launched or the launch date is determined when you apply
  • Representative (CEO, President etc.) can attend to the conference on Dec.10 to do the pitch*2

*1 As referring “healthtech”, we widely accept products/services that utilize technologies to improve “better life”, which includes medicine, caretaking, dietary, HR or others.

*2 Even if you're not selected as a finalist, applicants can pitch at the Lightning Pitch on the 1st day.

How to Apply

To apply for the competition, please fill the form shown on the website.
Travel expenses and accommodation costs for participating in the pitch are at your own expense.

Time Schedule

Time Schedule



Sumitomo Dainippon Pharma Co., Ltd.


Mitsubishi UFJ Research and Consulting Co.,Ltd.
Mitsui Fudosan


Recruit Holdings Co., Ltd.
Dai-chi Life

Booth Exhibitor

Melody International
Rim Tech
ReMark Japan

Media Partner

Pharma Information Network
Health Watch

Supported by

Japan Medical Association
Yo Iwami
Yo Iwami President & CEO (M.D, Ph.D), MedPeer, Inc.

Dr. Iwami graduated from the Shinshu University School of Medicine and joined the Department of Cardiovascular Medicine at Tokyo Women's Medical University in 1999.
Yo established Medical Oblige Inc (now MedPeer,Inc.) in December 2004.
He launched MedPeer in August 2007.
MedPeer is a professional online social media for certified doctors to share insight of actual medical scene and now it holds more than 100,000 doctors (one of three doctors in Japan).
He continues to be active on the front lines of clinical site, still holding patient consultations once a week.

Michikazu Koshiba
Michikazu Koshiba Head, Center on Global Health Architecture, General Manager, Social Impact Partnership Business Dept,  Mitsubishi UFJ Research and Consulting Co., Ltd.

He started his career in International Development/Humanitarian Relief fields. Serving for disaster-affected community, the concept of sustainability/multi-stakeholder approach became the essential value for his career. Shaping his career as a consultant to dedicate his life to CSV(Creating Shared Values) business, especially on global health from the mid-2000s, he has worked with scores of corporations and startups, as well as with industry bodies, government, the media, NGOs, academia.
His favorite word of his role: “nexus between conventional politics and one of the future” Since 2016, he established a P3 forum “Access to Health” where the members are focusing on a contribution to global health including Infectious Diseases, Nutrition, NCDs, MCH and health service delivery to transform health system. Digital health is a key component. He plays a role as a facilitator/coordinator for multi-stakeholders in a global arena, working as the HEAD, Center on Global Health Architecture, MITSUBISHI UFJ Research and Consulting.

Tak Miyata
Tak Miyata General Partner, Scrum Ventures

Tak has invested in over 60 startups related to commerce, health care, SaaS, video, and IoT in the U.S. Tak has international experience in the IT industry both as an entrepreneur and as a senior executive.

Kazuo Tsubota, MD, PhD, MBA
Kazuo Tsubota, MD, PhD, MBA Professor & Department Chair, Keio University School of Medicine

Prof. Kazuo Tsubota is an internationally recognized dry eye specialist who has been working on the pathogenesis and treatment of dry eye for much of his career. His latest research activities spotlight myopia due to the myopia boom affecting Japan and East Asia. His research focuses on the hypothesis that violet light has a suppressive effect against the progression of myopia and blue light’s role in determining circadian rhythm, mood, and memory. More recently, Prof. Tsubota is interested in innovation and is director of the innovation program at Keio University which encourages researchers to start venture companies based on their scientific findings. To set an example he established his own company, Tsubota Laboratory, Inc. which focuses on the clinical application of violet light for the control of myopia as well as dry eye and presbyopia. In addition, Prof. Tsubota has published over 700 scientific peer-reviewed articles.

Rami Suzuki PhD
Rami Suzuki PhD Head, Medical Affairs Division, Janssen Pharmaceuticals K.K.

Rami Suzuki Ph.D. is Head of Medical Affairs at Janssen Pharmaceuticals K.K., the Janssen Pharmaceutical Companies of Johnson & Johnson. Today she serves Ministry of Education, Culture, Sports, Science and Technology as Life Science Committee member as well as AMED and JST as an advisor to several projects. She was a selection committee member of Medical Science and Medicinal Science for Japan Prize 2018. She obtained Ph.D. in Medicine at University College London with a scholarship from Ludwig Institute for Cancer Research. Her post doctorial research was on breast cancer at Imperial College, London. She also worked as a venture capitalist for life sciences in London before joining the pharmaceutical industry. Her lifetime missions are to cure cancer and to prevent dementia.

Tak Umezawa
Tak Umezawa Japan Chairman, A.T. Kearney Chairman, CIC Japan

As Chairman of CIC Japan, Tak Umezawa is leading the effort to launch in 2020 CIC Tokyo, which will be the largest startup campus in the central Tokyo.
As Partner with A.T. Kearney, Umezawa has served leading corporations in Japan and the US for more than 20 years. Areas of his expertise include growth strategy, innovation and organization. He has served the firm as a Board Director, Japan MD, and the Global Leader of the Consumer Industries and Retail Practice.
Umezawa sits on government committees on Cool Japan, intellectual property, and inbound tourism. He is Adjunct Professor on leadership at Hitotsubashi ICS, Hitotsubashi University Business School.
Umezawa leads a multi-disciplinary, pro-bono team “NEXTOKYO.” The team has developed a future-city vision for Tokyo and works with property developers and municipalities on urban development projects in the city.
He has authored several books including “NEXTOKYO” (co-authored). He holds a bachelor of law from the University of Tokyo and an MBA from MIT Sloan School of Management.

Masao Okazaki
Masao Okazaki Client Partner Country Lead, Pfizer Digital Japan, Pfizer Holdings G.K.

Joined in Pfizer-Taito in 1983 as MR. Assigned as an initial member to establish a new medical device division of Pfizer in Japan. In 1992, he took the role of IT Manager of Pfizer Hospital Products Group. In 1996, he held a role of Senior IT Manager of Pfizer's Pharmaceutical division and supported its Sales and Marketing businesses and processes including SFA, SFE, CRM, eMarketing, Mobile etc. Senior Director, Business Technology in 1999 in Japan and New York HQ after 2002. Pfizer Digital Japan Lead since 2019.

Tomoyoshi Sato
Tomoyoshi Sato Representative Director CEO&CTO, AXION RESEARCH INC.

In Mar., 2000 I started IPFlex Inc. that provides dynamically recofigurable processors based on parallel data processing with cycle base data path changes, targeting moving picture processing for digital TV or smart phone application. In Oct., 2009 I started Atonarp Inc. that provides very companct Mass Spectrometer to be used for breath monitoring or environment air analysis, and Optical Spectrometer targetting the nonivasive quantitative measurement of blood inspection like blood glucose or HbA1c. We have Replica Generator to enable the data creation, very close to the measured data with keeping closely the correlation, the covariance and the probability density of those data. By the hybrid type engine of knowledge base engine and deep learning engine, we established AXiON Research Inc. in Dec., 2016 for inference of the individual health position and the future disease risk. We continue those challenge for the next future society happiness and people's big smiles there.

Shigeo Kohigashi
Shigeo Kohigashi CEO, Enishia,Inc.

After graduating from the Faculty of Economics at Osaka University in 1999, he worked for financial institutions, foreign accounting consulting companies and local governments. Experienced in large-scale group management management infrastructure development projects. Knowledge of project management from start-up to stable operation.
Acquired Kyoto University MBA (Service Value Creation Program) in 2017. Participated in the “Kyoto University Design School” that nurtures social system and architecture design personnel while in graduate school, the “EDGE Program” that nurtures global entrepreneurs, and “HiDEP” that nurtures medical healthcare innovation entrepreneurs.

Yutaka Shimokawa
Yutaka Shimokawa CEO, KINS

The former chairman of Iaso Kai Association of Medical Corporations, He worked at the clinic 6year and he also followed as Chairman 3years.
He provided medical treatment aggressively while focusing on management. Especially he approached the definitive care treatment on the bacteria flora for more than 2,500 chronic disease patients or designated intractable disease patients.
During his treatment, he found the lifestyle of the patients were “widely different from the proper daily life which need to live” during medical treatment, such as, bread with gluten, toothpaste with surfactant, processed food with lots of preservatives, and sweets with lots of sugar etc...
These series were creating chronic inflammation all over their body caused disturbing the balance of the symbiotic bacteria. He wanted to share this fact to more people for regaining proper daily life of the patients, and then he has founded KINS.

Adebayo Alonge
Adebayo Alonge CoFounder/CEO, RxAll Inc.

Market development professional with 10+ years experience developing 100M+ new business in Africa for BCG, BASF, Roche and Sanofi. Pharmacist with business & policy degrees from Yale and Harvard (in-view).

Tamaryn Hankinson
Tamaryn Hankinson Co-founder and Managing Director, The Clinician

Mrs. Tamaryn Hankinson graduated from Otago University in New Zealand with a 1st class honours degree in Neuroscience in 1998. Tamaryn worked in the pharmaceutical industry in Australia and the UK before moving into business intelligence in the healthcare sector in 2003 where she worked in senior executive positions for more than a decade across Europe and the US. In 2015 Dr. Ron Tenenbaum (a spinal surgeon with strong technological background) and Tamaryn formed the health software company The Clinician developing software solutions to support the global shift to value based care models. After launching their outcome and cost measurement platform ZEDOC in Singapore where they are now implementing naitonally, The Clinician also has significant traction in Israel and Australia, winning a national tender with the Australian Digital Health Agency to evaluate for national scalibility.

Matthew Holt
Matthew Holt Co-Chairman, Health2.0

Matthew Holt, Co-Chairman, spent the 1990s learning from the best to be a health care futurist at Institute for the Future, and a survey researcher at Harris Interactive. In the early 2000s he spent time at a PHR start-up, but since he’s been the Founder of (and now occasional author on) The Health Care Blog, and co-founder of the Health 2.0 Conference–roles for which he was mostly self-taught!

Shunichiro Ito
Shunichiro Ito CEO, AGREE Inc.
Yukiko Ito
Yukiko Ito CEO, ZEST Inc.